The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostaglandin-Global Market Insights and Sales Trends 2025
Synopsis
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostaglandin market size is expected to reach US$ 785.7 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Prostaglandin in various end use industries. The expanding demands from the Cardiovascular, Gynecological and Obstetrical, Ophthalmologic and Other, are propelling Prostaglandin market. Human Prostaglandin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Veterinary Prostaglandin segment is estimated at % CAGR for the next seven-year period.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostaglandin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostaglandin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostaglandin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostaglandin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostaglandin covered in this report include Sanofi CEPiA, Kyowa Hakko Pharma, Cayman Chemical, Yonsung Fine Chemicals, Johnson Matthey, Chirogate, Everlight Chemical, ANVI Pharma and AUSUN Pharmaceutical, etc.
The global Prostaglandin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Global Prostaglandin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostaglandin market, Segment by Type:
Human Prostaglandin
Veterinary Prostaglandin
Global Prostaglandin market, by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostaglandin market size is expected to reach US$ 785.7 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Prostaglandin in various end use industries. The expanding demands from the Cardiovascular, Gynecological and Obstetrical, Ophthalmologic and Other, are propelling Prostaglandin market. Human Prostaglandin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Veterinary Prostaglandin segment is estimated at % CAGR for the next seven-year period.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostaglandin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostaglandin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostaglandin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostaglandin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostaglandin covered in this report include Sanofi CEPiA, Kyowa Hakko Pharma, Cayman Chemical, Yonsung Fine Chemicals, Johnson Matthey, Chirogate, Everlight Chemical, ANVI Pharma and AUSUN Pharmaceutical, etc.
The global Prostaglandin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Global Prostaglandin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostaglandin market, Segment by Type:
Human Prostaglandin
Veterinary Prostaglandin
Global Prostaglandin market, by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Prostaglandin Market Overview
1.1 Prostaglandin Product Overview
1.2 Prostaglandin Market Segment by Type
1.2.1 Human Prostaglandin
1.2.2 Veterinary Prostaglandin
1.3 Global Prostaglandin Market Size by Type
1.3.1 Global Prostaglandin Market Size Overview by Type (2018-2029)
1.3.2 Global Prostaglandin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Prostaglandin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostaglandin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Prostaglandin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Prostaglandin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Prostaglandin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Prostaglandin Sales Breakdown by Type (2018-2023)
2 Global Prostaglandin Market Competition by Company
2.1 Global Top Players by Prostaglandin Sales (2018-2023)
2.2 Global Top Players by Prostaglandin Revenue (2018-2023)
2.3 Global Top Players by Prostaglandin Price (2018-2023)
2.4 Global Top Manufacturers Prostaglandin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostaglandin Market Competitive Situation and Trends
2.5.1 Prostaglandin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostaglandin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostaglandin as of 2022)
2.7 Date of Key Manufacturers Enter into Prostaglandin Market
2.8 Key Manufacturers Prostaglandin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostaglandin Status and Outlook by Region
3.1 Global Prostaglandin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Prostaglandin Historic Market Size by Region
3.2.1 Global Prostaglandin Sales in Volume by Region (2018-2023)
3.2.2 Global Prostaglandin Sales in Value by Region (2018-2023)
3.2.3 Global Prostaglandin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Prostaglandin Forecasted Market Size by Region
3.3.1 Global Prostaglandin Sales in Volume by Region (2024-2029)
3.3.2 Global Prostaglandin Sales in Value by Region (2024-2029)
3.3.3 Global Prostaglandin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Prostaglandin by Application
4.1 Prostaglandin Market Segment by Application
4.1.1 Cardiovascular
4.1.2 Gynecological and Obstetrical
4.1.3 Ophthalmologic
4.1.4 Other
4.2 Global Prostaglandin Market Size by Application
4.2.1 Global Prostaglandin Market Size Overview by Application (2018-2029)
4.2.2 Global Prostaglandin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Prostaglandin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostaglandin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Prostaglandin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Prostaglandin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Prostaglandin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Prostaglandin Sales Breakdown by Application (2018-2023)
5 North America Prostaglandin by Country
5.1 North America Prostaglandin Historic Market Size by Country
5.1.1 North America Prostaglandin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Prostaglandin Sales in Volume by Country (2018-2023)
5.1.3 North America Prostaglandin Sales in Value by Country (2018-2023)
5.2 North America Prostaglandin Forecasted Market Size by Country
5.2.1 North America Prostaglandin Sales in Volume by Country (2024-2029)
5.2.2 North America Prostaglandin Sales in Value by Country (2024-2029)
6 Europe Prostaglandin by Country
6.1 Europe Prostaglandin Historic Market Size by Country
6.1.1 Europe Prostaglandin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Prostaglandin Sales in Volume by Country (2018-2023)
6.1.3 Europe Prostaglandin Sales in Value by Country (2018-2023)
6.2 Europe Prostaglandin Forecasted Market Size by Country
6.2.1 Europe Prostaglandin Sales in Volume by Country (2024-2029)
6.2.2 Europe Prostaglandin Sales in Value by Country (2024-2029)
7 Asia-Pacific Prostaglandin by Region
7.1 Asia-Pacific Prostaglandin Historic Market Size by Region
7.1.1 Asia-Pacific Prostaglandin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Prostaglandin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Prostaglandin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Prostaglandin Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostaglandin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Prostaglandin Sales in Value by Region (2024-2029)
8 Latin America Prostaglandin by Country
8.1 Latin America Prostaglandin Historic Market Size by Country
8.1.1 Latin America Prostaglandin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Prostaglandin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Prostaglandin Sales in Value by Country (2018-2023)
8.2 Latin America Prostaglandin Forecasted Market Size by Country
8.2.1 Latin America Prostaglandin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Prostaglandin Sales in Value by Country (2024-2029)
9 Middle East and Africa Prostaglandin by Country
9.1 Middle East and Africa Prostaglandin Historic Market Size by Country
9.1.1 Middle East and Africa Prostaglandin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Prostaglandin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Prostaglandin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Prostaglandin Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostaglandin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Prostaglandin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi CEPiA
10.1.1 Sanofi CEPiA Company Information
10.1.2 Sanofi CEPiA Introduction and Business Overview
10.1.3 Sanofi CEPiA Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi CEPiA Prostaglandin Products Offered
10.1.5 Sanofi CEPiA Recent Development
10.2 Kyowa Hakko Pharma
10.2.1 Kyowa Hakko Pharma Company Information
10.2.2 Kyowa Hakko Pharma Introduction and Business Overview
10.2.3 Kyowa Hakko Pharma Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Kyowa Hakko Pharma Prostaglandin Products Offered
10.2.5 Kyowa Hakko Pharma Recent Development
10.3 Cayman Chemical
10.3.1 Cayman Chemical Company Information
10.3.2 Cayman Chemical Introduction and Business Overview
10.3.3 Cayman Chemical Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cayman Chemical Prostaglandin Products Offered
10.3.5 Cayman Chemical Recent Development
10.4 Yonsung Fine Chemicals
10.4.1 Yonsung Fine Chemicals Company Information
10.4.2 Yonsung Fine Chemicals Introduction and Business Overview
10.4.3 Yonsung Fine Chemicals Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Yonsung Fine Chemicals Prostaglandin Products Offered
10.4.5 Yonsung Fine Chemicals Recent Development
10.5 Johnson Matthey
10.5.1 Johnson Matthey Company Information
10.5.2 Johnson Matthey Introduction and Business Overview
10.5.3 Johnson Matthey Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson Matthey Prostaglandin Products Offered
10.5.5 Johnson Matthey Recent Development
10.6 Chirogate
10.6.1 Chirogate Company Information
10.6.2 Chirogate Introduction and Business Overview
10.6.3 Chirogate Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Chirogate Prostaglandin Products Offered
10.6.5 Chirogate Recent Development
10.7 Everlight Chemical
10.7.1 Everlight Chemical Company Information
10.7.2 Everlight Chemical Introduction and Business Overview
10.7.3 Everlight Chemical Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Everlight Chemical Prostaglandin Products Offered
10.7.5 Everlight Chemical Recent Development
10.8 ANVI Pharma
10.8.1 ANVI Pharma Company Information
10.8.2 ANVI Pharma Introduction and Business Overview
10.8.3 ANVI Pharma Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 ANVI Pharma Prostaglandin Products Offered
10.8.5 ANVI Pharma Recent Development
10.9 AUSUN Pharmaceutical
10.9.1 AUSUN Pharmaceutical Company Information
10.9.2 AUSUN Pharmaceutical Introduction and Business Overview
10.9.3 AUSUN Pharmaceutical Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AUSUN Pharmaceutical Prostaglandin Products Offered
10.9.5 AUSUN Pharmaceutical Recent Development
10.10 Aspen Biopharma Labs
10.10.1 Aspen Biopharma Labs Company Information
10.10.2 Aspen Biopharma Labs Introduction and Business Overview
10.10.3 Aspen Biopharma Labs Prostaglandin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Aspen Biopharma Labs Prostaglandin Products Offered
10.10.5 Aspen Biopharma Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostaglandin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostaglandin Industrial Chain Analysis
11.4 Prostaglandin Market Dynamics
11.4.1 Prostaglandin Industry Trends
11.4.2 Prostaglandin Market Drivers
11.4.3 Prostaglandin Market Challenges
11.4.4 Prostaglandin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostaglandin Distributors
12.3 Prostaglandin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
